BGY
BEARISH
$5.97
Live
BlackRock Enhanced International Dividend Trust · NYSE
$4.67
52W Range
$6.0
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$554.84M
P/E
45.92
ROE
7.0%
Profit margin
283.6%
Debt/Equity
N/A
Dividend yield
8.56%
AI Analysis
AI-powered fundamental assessment
Confidence
68%
The Advanced Deterministic Scorecard shows a strong Piotroski F-Score of 7/9, indicating solid financial health, but the absence of an Altman Z-Score limits distress risk assessment. Despite high profitability margins and strong historical price performance, the stock trades at a steep valuation (P/E 45.92 vs. sector avg 31.01) with declining revenue and an unsustainable dividend payout ratio of 366.15%. Technical trend is deeply bearish (10/100), and lack of analyst coverage further increases uncertainty. These factors outweigh the strong F-Score and high yield, leading to a bearish outlook.
Key Strengths
Strong Piotroski F-Score of 7/9 suggests robust financial health based on earnings quality, leverage, and operating efficiency.
Exceptionally high profitability: 283.59% profit margin and 65.88% operating margin far exceed sector averages.
Attractive dividend yield of 8.56%, above most income-generating peers in financial services.
Solid historical price performance: +46.6% over 5 years and +18.4% in the past year.
Price/Book of 0.95 suggests near-book valuation, potentially indicating limited downside from asset liquidation perspective.
Key Risks
Extremely high P/E ratio of 45.92 versus sector average of 31.01, signaling overvaluation relative to earnings.
Unsustainable dividend payout ratio of 366.15%, indicating dividends are not covered by earnings and may be cut.
Revenue declining YoY by -12.10%, conflicting with positive earnings growth and raising quality concerns.
Very weak technical trend score of 10/100, suggesting strong near-term bearish momentum.
No analyst coverage and missing key financials (e.g., debt/equity, cash flow, shares outstanding) increase information risk.
AI Fair Value Estimate
Based on comprehensive analysis
$4.05
-32.2% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
46
Moderate
25
42
65
70
30
AI Verdict
Overvalued with structural risks outweighing financial stability
Key drivers: High P/E and Price/Sales ratios, Negative revenue growth, Unsustainable dividend payout, Strong Piotroski F-Score, Lack of analyst and fundamental transparency
Confidence
72%
Value
25/100
Ref P/E, PEG, Graham Number
Positives
- Price/Book ratio of 0.95 is below 1, suggesting possible book value support
Watchpoints
- P/E of 45.92 is significantly above sector average of 31.01
- Price/Sales of 37.26 is extremely high, indicating premium pricing without sales justification
- Current price ($5.97) is 39.9% above Graham Number ($4.28) and 57.7% above intrinsic value ($3.83)
Future
42/100
Ref Growth rates
Positives
- Earnings growth YoY of 132.60% and Q/Q of 110.20% show strong recent earnings momentum
Watchpoints
- Revenue growth YoY is -12.10%, indicating top-line contraction despite earnings growth
- No forward P/E or growth guidance available, increasing uncertainty
Past
65/100
Ref Historical trends
Positives
- 5-year price return of +46.6% shows strong long-term capital appreciation
- 1-year return of +18.4% outperforms many peers
- 52-week high near current price suggests resistance level
Watchpoints
- Recent momentum slowing: 1-month return +3.0%, 1-week +0.6%
Health
70/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 7/9 indicates strong financial health across profitability, leverage, and operating efficiency
- Gross margin of 100% suggests pure fee-based or asset-light model with no cost of goods sold
Watchpoints
- Current ratio of 0.76 and quick ratio of 0.73 indicate potential short-term liquidity pressure
- Altman Z-Score not available, limiting distress risk evaluation
- Missing debt, cash, and ROIC data reduces confidence in full health picture
Dividend
30/100
Ref Yield, Payout
Positives
- High dividend yield of 8.56% provides strong income appeal
Watchpoints
- Payout ratio of 366.15% is unsustainable and signals dividend not earnings-backed
- Dividend strength score of 40/100 indicates structural weakness in coverage and consistency
- No 5-year average yield data to assess stability
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$5.97
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BGY and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BGY
BlackRock Enhanced International Dividend Trust
Primary
|
+46.6% | +41.8% | +18.4% | +7.6% | +3.0% | +0.6% |
|
GUT
The Gabelli Utility Trust
Peer
|
+44.3% | +24.3% | +29.5% | +8.5% | +6.1% | +2.5% |
|
ACIC
American Coastal Insurance Corporation
Peer
|
+65.7% | +399.5% | +1.6% | +9.0% | +2.3% | -2.8% |
|
AVK
Advent Convertible and Income Fund
Peer
|
+43.6% | +52.3% | +17.8% | +9.9% | +1.6% | +0.3% |
|
BME
BlackRock Health Sciences Trust
Peer
|
+19.4% | +22.4% | +13.7% | +20.6% | +2.5% | +1.8% |
BGY
BlackRock Enhanced International Dividend Trust
Primary
5Y
+46.6%
3Y
+41.8%
1Y
+18.4%
6M
+7.6%
1M
+3.0%
1W
+0.6%
GUT
The Gabelli Utility Trust
Peer
5Y
+44.3%
3Y
+24.3%
1Y
+29.5%
6M
+8.5%
1M
+6.1%
1W
+2.5%
ACI
American Coastal Insurance Corporation
Peer
5Y
+65.7%
3Y
+399.5%
1Y
+1.6%
6M
+9.0%
1M
+2.3%
1W
-2.8%
AVK
Advent Convertible and Income Fund
Peer
5Y
+43.6%
3Y
+52.3%
1Y
+17.8%
6M
+9.9%
1M
+1.6%
1W
+0.3%
BME
BlackRock Health Sciences Trust
Peer
5Y
+19.4%
3Y
+22.4%
1Y
+13.7%
6M
+20.6%
1M
+2.5%
1W
+1.8%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
45.92
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.95
P/S Ratio
37.26
EV/Revenue
36.1
EV/EBITDA
N/A
Market Cap
$554.84M
Profitability
Profit margins and return metrics
Profit Margin
283.59%
Operating Margin
65.88%
Gross Margin
100.0%
ROE
7.05%
ROA
0.81%
Growth
Revenue and earnings growth rates
Revenue Growth
-12.1%
Earnings Growth
+132.6%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+110.2%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
0.76
Weak
Quick Ratio
0.73
Poor
Cash/Share
$0.04
Financial Services Sector Comparison
Comparing BGY against 820 companies in the Financial Services sector
(141 bullish, 351 neutral, 328 bearish)
P/E Ratio
45.92
This Stock
vs
36.01
Sector Avg
+27.5%
(Expensive)
Return on Equity (ROE)
7.05%
This Stock
vs
-0.73%
Sector Avg
-1061.8%
(Below Avg)
Profit Margin
283.59%
This Stock
vs
91.62%
Sector Avg
+209.5%
(Superior)
Revenue Growth
-12.1%
This Stock
vs
35.27%
Sector Avg
-134.3%
(Slower)
Current Ratio
0.76
This Stock
vs
3.18
Sector Avg
-76.1%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BGY
BlackRock Enhanced...
|
BEARISH | $554.84M | 45.92 | 7.0% | 283.6% | $5.97 | |
|
GUT
The Gabelli Utility Trust
|
NEUTRAL | $556.41M | 11.5 | 15.0% | 421.4% | $6.21 | Compare |
|
ACIC
American Coastal Insurance...
|
BEARISH | $551.54M | 6.54 | 38.6% | 31.9% | $11.31 | Compare |
|
AVK
Advent Convertible and Income Fund
|
BEARISH | $563.34M | 4.73 | 21.1% | 286.0% | $12.76 | Compare |
|
BME
BlackRock Health Sciences Trust
|
BEARISH | $545.27M | - | -4.6% | -% | $42.19 | Compare |
BGY
BlackRock...
BEARISH
Mkt Cap
$555M
P/E
45.9
ROE
7.0%
Price
$5.97
Past News Coverage
Recent headlines mentioning BGY from our newsroom.
Newest → oldest
No matching news yet.